The findings from the in vivo mouse model demonstrated that the administration of LipC6 effectively suppressed tumor growth by decreasing tumor cell proliferation and Akt phosphorylation and promoting tumor cell apoptosis. The gene discussed is AKT1; the disease is neoplasm.